Franklin Resources’s Aptose Biosciences, Inc. APTO Stock Holding History

Franklin Resources’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,941	Closed	-$1.34M	–	1541
2017 Q1	$1.34M	Hold	2,941	–	–	﹤0.01%	1292
2016 Q4	$1.78M	Sell	2,941 -207	-7%	-$129K	﹤0.01%	1251
2016 Q3	$3.19M	Hold	3,148	–	–	﹤0.01%	1184
2016 Q2	$3.51M	Hold	3,148	–	–	﹤0.01%	1156
2016 Q1	$4.17M	Hold	3,148	–	–	﹤0.01%	1131
2015 Q4	$3.69M	Hold	3,148	–	–	﹤0.01%	1187
2015 Q3	$6.16M	Hold	3,148	–	–	﹤0.01%	1108
2015 Q2	$7.26M	Hold	3,148	–	–	﹤0.01%	1101
2015 Q1	$7.65M	Hold	3,148	–	–	﹤0.01%	1098
2014 Q4	$8.38M	Buy	+3,148	New	+$9.47M	﹤0.01%	1080

Other funds holding APTO

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Franklin Resources's APTO Position: Q2 2017 in Review

Franklin Resources sold out of Aptose Biosciences, Inc. (APTO) in Q2 2017, closing a stake of 2,941 shares — an estimated $1.34M sold.

Franklin Resources first reported a position in APTO in Q4 2014 and held it in 10 quarters. The position peaked at $8.38M in Q4 2014. 10 funds tracked by Wall St. Rank hold APTO as of Q2 2017.

Franklin Resources reported no remaining Aptose Biosciences, Inc. position as of Q2 2017 after selling out during the quarter.
Franklin Resources sold 2,941 Aptose Biosciences, Inc. shares in Q2 2017, an estimated $1.34M.
Franklin Resources first reported a position in Aptose Biosciences, Inc. in Q4 2014 and held it in 10 quarters.
Franklin Resources's Aptose Biosciences, Inc. position peaked at $8.38M in Q4 2014.
10 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2017.

Based on Franklin Resources's 13F filing for Q2 2017, filed 10 Aug 2017.